NextPlat (NXPL) EBITDA Margin (2015 - 2026)
NextPlat (NXPL) posted EBITDA Margin of -0.45% for Q2 2026, up 12.04 percentage points from -12.49% a year earlier and up 9.92 percentage points from the prior quarter.
Powered by 
Analysis
NextPlat (NXPL) EBITDA Margin (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at NextPlat was -13.49%, up 8.91 percentage points year-over-year; for FY2025, it came in at -15.40%, up 15.65 percentage points from FY2024.
- Annual EBITDA Margin has increased for four consecutive years, with a five-year change of +15.17 percentage points (FY2020 to FY2025).
- In prior years, NextPlat's EBITDA Margin was -31.05% in FY2024 (+24.82 pp), -55.86% in FY2023 (+1.47 pp), -57.33% in FY2022 (+24.14 pp) and -81.46% in FY2021 (-50.90 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q3 2015.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +14.30 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2024, with a gain of 72.92 percentage points; the weakest was Q4 2021, with a drop of 94.08 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -10.37% (Q1 2026), -28.15% (Q4 2025) and -13.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | NextPlat | 24.55 Mn | -25.93 Mn | 4.69 Mn | -0.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.45% |
| Mar 31, 2026 | -10.37% |
| Dec 31, 2025 | -28.15% |
| Sep 30, 2025 | -13.34% |
| Jun 30, 2025 | -12.49% |
| Mar 31, 2025 | -13.69% |
| Dec 31, 2024 | -12.81% |
| Sep 30, 2024 | -48.95% |
| Jun 30, 2024 | -58.86% |
| Mar 31, 2024 | -5.37% |
| Dec 31, 2023 | -85.73% |
| Sep 30, 2023 | -16.79% |
| Jun 30, 2023 | -107.88% |
| Mar 31, 2023 | -37.31% |
| Dec 31, 2022 | -96.13% |
| Sep 30, 2022 | -77.14% |
| Jun 30, 2022 | -49.46% |
| Mar 31, 2022 | -20.54% |
| Dec 31, 2021 | -166.29% |
| Sep 30, 2021 | -95.92% |
API Access
NextPlat EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NXPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NXPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NXPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();